Axa’s PRA Health Sciences, Inc. PRAH Stock Holding History

Axa’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-61,714	Closed	-$10.2M	–	1362
2021 Q2	$10.2M	Sell	61,714 -15,792	-20%	-$2.64M	0.03%	507
2021 Q1	$11.9M	Sell	77,506 -1,799	-2%	-$244K	0.04%	474
2020 Q4	$9.95M	Hold	79,305	–	–	0.03%	524
2020 Q3	$8.04M	Buy	79,305 +15,424	+24%	+$1.57M	0.03%	519
2020 Q2	$6.21M	Buy	+63,881	New	+$5.94M	0.02%	549
2020 Q1	–	Sell	-1,900	Closed	-$211K	–	1279
2019 Q4	$211K	Buy	+1,900	New	+$195K	﹤0.01%	1122
2019 Q3	–	Sell	-2,900	Closed	-$287K	–	1376
2019 Q2	$287K	Hold	2,900	–	–	﹤0.01%	1171
2019 Q1	$320K	Buy	+2,900	New	+$303K	﹤0.01%	1182
2016 Q3	–	Sell	-41,700	Closed	-$1.74M	–	1393
2016 Q2	$1.74M	Buy	41,700 +31,500	+309%	+$1.45M	0.01%	763
2016 Q1	$436K	Buy	+10,200	New	+$431K	﹤0.01%	1018

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Axa's PRAH Position: Q3 2021 in Review

Axa sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 61,714 shares — an estimated $10.2M sold.

Axa first reported a position in PRAH in Q1 2016 and held it in 10 quarters. The position peaked at $11.9M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Axa reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Axa sold 61,714 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $10.2M.
Axa first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 10 quarters.
Axa's PRA Health Sciences, Inc. position peaked at $11.9M in Q1 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.